Abiopharma

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)

Matt Arens, CEO and Founder of Health Catalysts Largest Shareholder, First Light Asset Management, Joins Board of Directors

ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise

Ensign Group - The Ensign Group Adds Real Estate and Operations in Kansas

Ensign Group - The Ensign Group Increases Operations in Arizona